By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Use. You can change your cookie settings through your browser.
In an interview with CGTN, Nobel laureate Randy Schekman discusses the urgent need for new therapeutic targets, the role of alpha-synuclein in Parkinson's disease, and how research into irisin – a peptide linked to exercise – could open new avenues for treatment.
From understanding disease mechanisms to exploring new treatment possibilities, scientific discovery offers hope for the future.
In an interview with CGTN, Nobel laureate Randy Schekman discusses the urgent need for new therapeutic targets, the role of alpha-synuclein in Parkinson's disease, and how research into irisin – a peptide linked to exercise – could open new avenues for treatment.
From understanding disease mechanisms to exploring new treatment possibilities, scientific discovery offers hope for the future.
Executive producer: Zhang Jingwen
Producer: Yang Sha
Reporter and editor: Zhang Yuying
Videographer: Wang Hongjie
Copy editors: Zhou Jun, Chen Chen, Zaruhi
Visual designer: Du Chenxin